Cargando…
EGCG, a Green Tea Catechin, as a Potential Therapeutic Agent for Symptomatic and Asymptomatic SARS-CoV-2 Infection
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has emerged to be the greatest threat to humanity in the modern world and has claimed nearly 2.2 million lives worldwide. The United States alone accounts for more than one fourth of 100 mill...
Autores principales: | Chourasia, Mukesh, Koppula, Purushotham Reddy, Battu, Aruna, Ouseph, Madhu M., Singh, Anil K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956763/ https://www.ncbi.nlm.nih.gov/pubmed/33668085 http://dx.doi.org/10.3390/molecules26051200 |
Ejemplares similares
-
Targeting Receptor Tyrosine Kinases for Chemoprevention by Green Tea Catechin, EGCG
por: Shimizu, Masahito, et al.
Publicado: (2008) -
Green Tea Catechin (-)-Epigallocatechin-3-Gallate (EGCG) Facilitates Fracture Healing
por: Lin, Sung-Yen, et al.
Publicado: (2020) -
The green tea catechin EGCG provides proof-of-concept for a pan-coronavirus attachment inhibitor
por: LeBlanc, Emmanuelle V., et al.
Publicado: (2022) -
The Green Tea Catechin Epigallocatechin Gallate (EGCG) Blocks Cell Motility, Chemotaxis and Development in Dictyostelium discoideum
por: McQuade, Kyle J., et al.
Publicado: (2013) -
Green tea catechins EGCG and ECG enhance the fitness and lifespan of Caenorhabditis elegans by complex I inhibition
por: Tian, Jing, et al.
Publicado: (2021)